David Chang

Response to belimumab among patients with systemic lupus erythematosus in clinical practice settings: 24-month results from the OBSErve study in the USA

Lupus Science & Medicine · 2016 · Last of 7 authors · 97 citations

Randomised clinical trial: vercirnon, an oral CCR9 antagonist, vs. placebo as induction therapy in active Crohn's disease

Alimentary Pharmacology & Therapeutics · 2015 · Last of 13 authors · 84 citations